Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NovaSOL astaxanthin is a **micellar formulation of natural astaxanthin** developed by Aquanova that exhibits **superior antioxidant, anti-inflammatory, and neuroprotective properties** compared to standard astaxanthin formulations[1][3][5][7][10]. The micellar technology employed in NovaSOL increases the solubility and bioavailability of astaxanthin, resulting in more rapid and higher plasma concentrations following oral administration, which may enhance its therapeutic efficacy[7][10]. Astaxanthin itself is a carotenoid obtained from the microalgae *Haematococcus pluvialis*; this compound is not converted to vitamin A, does not show pro-oxidant activity, and must be supplied through diet[1][3][5]. NovaSOL astaxanthin is clinically studied for benefits including improved **skin health, muscle recovery, joint function, cardiovascular protection, neurological support, and immune modulation**, with demonstrated improvements in objective and subjective parameters of skin texture, hydration, and redness in human studies[9][12]. Its mechanisms of action involve **scavenging free radicals, enhancing endogenous antioxidant systems (ROS/RNS, SOD, GPX, Nrf2), modulating inflammatory pathways (NF-κB, MAPK, COX-2, IL-6, iNOS), regulating apoptosis (Bcl-2, p53, cyclin D1), improving metabolic and insulin signaling (PPARs, AMPK, IRS/PI3K/Akt), and protecting mitochondrial membranes**[2]. These distinct molecular and cellular impacts position NovaSOL astaxanthin as a nutraceutical for healthy aging, skin rejuvenation, muscle endurance/recovery, neurocognitive protection, and broad support of cardiovascular and immune function[1][3][5][9][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NovaSOL astaxanthin.